Scarlet Therapeutics

Activities: Research & Development

Trending Articles

  1. Johnson & Johnson completes V-Wave acquisition to support patients with heart failure The strategic acquisition will bolster the pharma giant's MedTech offerings for patients with cardiovascular disease
  2. Aveva World 2024 highlights increasing efficiency with Shiftconnector and AI Live demo to showcase real-time data and AI-powered troubleshooting
  3. Rousselot Rousselot is the global leader* of collagen-based solutions for the food, health and nutrition, biomedical and pharmaceutical sectors. Working in partnership with our global...
  4. Merck's MilliporeSigma cuts the ribbon on €290m US biosafety and analytical facility The site will host biosafety testing, analytical development and cell banking manufacturing services
  5. Hubble Therapeutics selects Andelyn Biosciences to manufacture its AAVs The CDMO will be responsible for the manufacture of adeno-associated viruses in order to treat leber congenital amaurosis 16

Upcoming event

ISCC

15-18 October 2024 | Conference | Milan, Italy See all

Related Content

Drug Delivery

Scarlet Therapeutics raises seed funding for rare disease treatment therapies

The platform also has the potential to treat other metabolic diseases requiring enzyme replacement therapy, as well as cancer and autoimmune diseases
Subscribe now